Related Experiment Video
Updated: May 10, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Added value of PCR-testing for confirmation of invasive meningococcal disease in England
Ellen Heinsbroek1, Shamez Ladhani, Steve Gray
1European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; Immunisation, Hepatitis & Blood Safety Department, Public Health England, London, United Kingdom.
Objectives:
In England, national guidance recommends that all patients with suspected invasive meningococcal disease (IMD) should be investigated by blood culture and polymerase chain reaction (PCR) testing. The Meningococcal Reference Unit (MRU) provides a national service for meningococcal species confirmation and PCR-testing of clinical samples. We performed a population-level assessment of the added value of PCR-testing for IMD to augment traditional culture confirmation.
Methods:
We analysed all PCR-samples and invasive meningococcal isolates received by MRU in 2009 and 2010. We assumed that all patients with PCR-samples submitted to MRU also had blood cultures performed and that positive blood cultures were referred to MRU. We confirmed this assertion by case ascertainment.
Results:
In total, 25,379 specimens from 22,039 patients were submitted for PCR-testing and 1492 (6.8%) tested PCR-positive. MRU received 825 invasive meningococcal isolates; 393 confirmed by PCR and culture, 405 without a PCR-specimen submitted and 27 with a PCR-negative result. Thus, of 1924 reported IMD cases, 1099 (57.1%) were confirmed by PCR only, 432 (22.5%) by culture only and 393 (20.4%) by both tests.
Conclusion:
More than half of all confirmed IMD cases were confirmed by PCR only, indicating this service ensures high case ascertainment for national surveillance.
Insights
Polymerase chain reaction (PCR) testing confirms over half of invasive meningococcal disease (IMD) cases, significantly improving national surveillance. This molecular diagnostic method enhances case ascertainment beyond traditional blood cultures.
Area of Science:
- Microbiology
- Infectious Diseases
- Molecular Diagnostics
Background:
- National guidelines in England mandate blood culture and PCR testing for suspected invasive meningococcal disease (IMD).
- The Meningococcal Reference Unit (MRU) offers national services for IMD confirmation and PCR testing.
- A population-level assessment was conducted to evaluate the added value of PCR testing for IMD.
Purpose of the Study:
- To assess the added value of PCR testing in augmenting traditional culture confirmation for invasive meningococcal disease (IMD).
- To evaluate the contribution of PCR testing to national surveillance of IMD.
Main Methods:
- Analysis of all PCR samples and invasive meningococcal isolates submitted to the MRU during 2009-2010.
- Assumption that all patients with PCR samples also had blood cultures performed, with positive cultures referred to MRU.
- Case ascertainment was used to confirm the assertion of concurrent blood culture performance.
Main Results:
- A total of 25,379 specimens from 22,039 patients were tested via PCR, with 1492 (6.8%) testing positive.
- MRU received 825 invasive meningococcal isolates; 393 were confirmed by both PCR and culture.
- Out of 1924 reported IMD cases, 1099 (57.1%) were confirmed by PCR only, 432 (22.5%) by culture only, and 393 (20.4%) by both.
Conclusions:
- PCR testing alone confirmed over half of all invasive meningococcal disease (IMD) cases.
- The national PCR testing service ensures high case ascertainment for IMD surveillance.
- PCR testing significantly enhances the detection of IMD compared to culture alone.
More Related Videos
Related Concept Videos
Bacterial Meningitis I: Introduction
Pneumonia III: Complications and Assessment
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
